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), such as 1-pentene, 2-pentene, 2-methyl-but-1-en (3-methyl-1-butene), 2-methyl-
but-2-en (isopentene), and 3-methyl-but-1-en.We investigated bacterial mutagenicity of 1-pentene, 2-pentene, and 3-methyl-but-1-
en in the Ames test. 2-Pentene was investigated as racemate and as pure diastereomers.We included themethyltransferase deficient
Salmonella Typhimurium strain YG7108 and the application of a gas-tight preincubation to reduce the risk of false negative
results. 1,2-Epoxypentane which may arise from 1-pentene was used as positive control. None of the investigated amylenes showed
mutagenic effects, whereas 1,2-epoxypentane was mutagenic exceeding 100 𝜇g per plate. An exceptional high reverse mutation
in the negative control plates in the experiments with 1,2-epoxypentane was obviously caused by evaporation into the incubator
which was shown by placing the control plates in a separate apparatus. No differences were seen upon use of YG7108 and its parent
strain TA1535. In conclusion, 1,2-epoxypentane is most probably not a substrate of the deleted bacterial methyltransferases. The
comparison of the bacterial mutagenicity of the investigated amylenes and 1,2-epoxipentane suggests that epoxidation of amylenes
in the S9-mix does not proceed effectively or is counterbalanced by detoxifying reactions. The assessment of mutagenic effects of
short chained aliphatic epoxides can be underestimated due to the evaporation of these compounds.
1. Introduction





), including unbranched compounds such as 1- and 2-
pentene (𝛼- and 𝛽-amylene) as well as branched compounds
such as 2-methyl-but-2-en (isopentene) [CAS 513-35-9] and
3-methyl-1-butene [CAS 563-45-1] (Figure 1). Amylenes are
used in the synthesis of amylphenols, isoprene, and pen-
tanoles and can occur in gasoline or diesel fuel [1]. In addition
amylenes are used as stabilizers in solvents; dichloromethane
(DCM), for example, can contain up to 40 ppm.
Short chained unsaturated hydrocarbons react with bio-
logical molecules by electrophilic addition and can easily
be epoxidized [2]. Both reactions can lead to mutagenic
effects [3]. Theoretically, amylenes may react in a similar
way. Short chained aliphatic epoxides such as ethylene oxide,
1,2-epoxypropane, and 1,2-epoxybutane are mutagenic in the
bacterial reversemutation assay [3]. Epoxidation of 1-pentene
is expected to yield 1,2-epoxypentane (propyloxirane). A
study which is available at ECHA reports week mutagenic-
ity of 1,2-epoxypentane at and above 5000𝜇g/plate [4].
Therefore, mutagenic properties of amylenes are suspected.
However, available toxicological data of most amylenes are
fragmentary despite their frequent use. The available data
show no bacterial mutagenicity for 1-pentene [5]. We were
not able to identify studies which investigated bacterial
mutagenicity of cis- and trans-2-pentene and 3-methyl-1-
butene.
Amylenes and their possible oxidation products show
close structural relationship to known mutagens and car-
cinogens. However, chain length and structure have a strong
impact on the mutagenicity of such short chained epoxides: a
methyl group in or near the oxirane ring prevents mutagenic
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Table 1: Reverse mutations for positive and negative controls.
Strain TA98 TA100 YG7108
Solvent control −S9 18 ± 6 (𝑁 = 16) 120 ± 17 (𝑁 = 17) 20 ± 6 (𝑁 = 18)
+S9 20 ± 7 (𝑁 = 20) 145 ± 19 (𝑁 = 15) 26 ± 9 (𝑁 = 19)
Gas-tight −S9 19 ± 7 (𝑁 = 10) 128 ± 18 (𝑁 = 9) 24 ± 9 (𝑁 = 13)
+S9 21 ± 4 (𝑁 = 20) 141 ± 18 (𝑁 = 12) 23 ± 6 (𝑁 = 17)
Not gas-tight:
3-NBA, 5 ng −S9 709 ± 328 (𝑁 = 12)
MMS, 200 𝜇g −S9 1516 (𝑁 = 1) 805 ± 283 (𝑁 = 10)
MMS, 500 𝜇g −S9 968 ± 175 (𝑁 = 13)
MMS, 1000 𝜇g −S9 1543 ± 40 (𝑁 = 2)
2-AF +S9 843 ± 228 (𝑁 = 19) 646 ± 117 (𝑁 = 13)
2-AA, 5𝜇g +S9 781 ± 52 (𝑁 = 3)
2-AA, 10 𝜇g +S9 486 ± 175 (𝑁 = 3)
NDEA, 500 𝜇g +S9 225 ± 85 (𝑁 = 11)
NDEA, 1000 𝜇g +S9 414 ± 360 (𝑁 = 16)
3-NBA: 3-nitrobenzanthrone; 2AF: 2-aminofluorene; 2-AA: 2-aminoanthracene; MMS: methyl methanesulfonate; NDEA:𝑁-nitrosodimethylamine.
effects in case of the isoprenemonoepoxide. Isoprene-dioxide
(2-methyl-1,2,3,4-diepoxybutane) on the other hand is strong
mutagenic [6].The same is true for 2,3-epoxybutane which is
a direct mutagen, whereas its 2-methyl derivative shows no
mutagenicity [7].
The detection of mutagenic effects of low molecular
weight compounds can be hampered by several factors such
as evaporation [8, 9] and bacterial DNA repair [10].The latter
was first demonstrated using methyltransferase deficient
tester strains such as YG7108 (ogt− and ada−) [11]. In addition,
strong stereoselective effects regarding mutagenicity were
reported in case of cis- and trans-2,3-epoxybutane [12] and for
the diastereoisomers of 3-bromo-1,2-epoxycyclohexane [13].
We therefore compared 1-pentene, 2-pentene, cis- and trans-
2-pentene, 3-methyl-but-1-en, and 1,2-epoxypentane in the
bacterial reverse mutation test.
2. Methods
We investigated 1-pentene [CAS 109-67-1], 2-pentene [CAS
109-68-2], cis- [CAS 627-20-3] and trans-2-pentene [CAS
646-04-8], 3-methyl-1-butene [CAS 563-45-1] (Sigma-
Aldrich, Steinheim, Germany), and 1,2-epoxypentane
[CAS 1003-14-1] (CHEMOS GmbH, Regenstauf, Germany)
using the bacterial reverse mutation assay, with the S.
Typhimurium strains TA98, TA100, TA1535 [14] (TA1535
only in case of 1,2-epoxypentane), and the methyltransferase
deficient tester strain YG7108 (ogt−, ada−) which is derived
from TA1535 [11]. The test was carried out with and without
metabolic activation by rat liver enzymes (S9) as well as
gastight preincubation in gas-tight autosampler vials [8].
Since 3-methyl-1-butene is gaseous at room temperature it
was withdrawn from a pressure cylinder and condensed
at approximately –18∘C using an ice/NaCl mixture. The
condensate was filled in a headspace vial and transferred
with a gas-tight syringe to the autosampler vials which
contained the tester strains and the S9-mix or equivalent
amounts of phosphate buffered saline.
We performed at least two independent experiments
for every substance. The compounds were tested up to
toxic concentrations but not above 5000 𝜇g/plate. Acceptance
criteria for a positive test were positive and negative controls
within the range of the historical controls (see Table 1) and a
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Table 2: Overview of all other results, not displayed as a figure.
Compound Strain Condition Result
1-Pentene
TA98 ±S9, gas-tight (𝑁 = 3) and not gas-tight (𝑁 = 7) Negative
TA100 ±S9, gas-tight (𝑁 = 2) and not gas-tight (𝑁 = 7) Negative
YG7108 ±S9, gas-tight (𝑁 = 5) and not gas-tight (𝑁 = 7) Negative
2-Pentene (racemate)
TA98 ±S9, gas-tight (𝑁 = 4) and not gas-tight (𝑁 = 4) Negative
TA100 ±S9, gas-tight (𝑁 = 3) and not gas-tight (𝑁 = 4) Negative
YG7108 ±S9, gas-tight (𝑁 = 3) and not gas-tight (𝑁 = 4) Negative
cis-2-pentene
TA98 ±S9, not gas-tight (𝑁 = 3) Negative
TA100 ±S9, not gas-tight (𝑁 = 4) Negative
YG7108 ±S9, not gas-tight (𝑁 = 3) Negative
trans-2-pentene
TA98 ±S9, not gas-tight (𝑁 = 3) Negative
TA100 ±S9, not gas-tight (𝑁 = 4) Negative
YG7108 ±S9, not gas-tight (𝑁 = 3) Negative
3-Methyl-1-butene
TA98 −S9, not gas-tight (𝑁 = 2) Negative
TA100 −S9, not gas-tight (𝑁 = 2) Negative
YG7108 −S9, not gas-tight (𝑁 = 5) Negative
reproducible, dose-dependent increase of reverse mutations
across at least 2 consecutive concentrations, with amaximum
exceeding the base rate by at least two times [15]. Counting
was performed by an automatic colony counter (BioCount,
Bio-Sys GmbH, Karben, Germany).
Chemicals and Test Compounds. Phenobarbital/𝛽-naphtho-
flavone induced S9 was purchased from MOLTOX, Tri-
nova Biochem GmbH (Giessen, Germany). 1-Pentene, 2-
pentene, cis- and trans-2-pentene, and 3-methyl-1-butene
(95% purity, Sigma-Aldrich, Steinheim, Germany) were
freshly dissolved in DMSO prior to each experiment. 1,2-
Epoxypentane (98%), methyl methane sulfonate (99%), 𝑁-
nitrosodiethylamine (99%), 2-aminofluorene (97%), and
2-aminoanthracene (95%) were purchased from Sigma-
Aldrich, Steinheim, Germany. 3-Nitrobenzanthrone (99%)
was purchased fromBiochemical Institute for Environmental
Carcinogens, Professor Dr. Gernot Grimmer-Foundation,
Grosshansdorf, Germany.
Calculations ofmeans and standard deviations were done
using commercial software (GraphPad Prism version 4.00 for
Windows, GraphPad Software, San Diego California USA).
3. Results
1,2-Epoxypentanewasmutagenic in TA1535, YG7108 (Figures
2(a) and 2(b)), and TA100 (data not shown), exceeding the
spontaneousmutation rate up to about 6-fold. Nomutagenic-
ity occurred in TA98 (data not shown). Notable differences
of the response of 1,2-epoxypentane in TA1535 and YG7108
were not seen (Figures 2(a) and 2(b)). Remarkably the assay
with 1,2-epoxypentane led to a strongly elevated spontaneous
mutation rate (Figure 2(b), standard conditions). This was
avoided by placing the control plates in a separate incubator
(Figure 2(a)).
1-Pentene, 2-pentene, cis- and trans-2-pentene, and 3-
methyl-1-butene were not mutagenic in any tester strain or
under any test condition, summarized in Table 2. All tests
with the amylenes were done with and without metabolic
activation.
Toxic effects occurred with and without addition of
S9-mix, apparent by microcolony induction or reduced
colony counts (latter is exemplarily shown in Figure 3).
The racemate of 2-pentene revealed no toxicity in TA100
under standard conditions up to the highest tested amount
of 5000𝜇g/plate but according to the experiments using
gas-tight preincubation the compound was toxic at and
above 1000 𝜇g/plate. Accordingly toxicity occurred inYG7108
at and above 1500𝜇g/plate upon gas-tight preincubation,
whereas no toxicity was seen up to 2500 𝜇g/plate under
standard conditions.
In case ofmicrocolony inductionmore closely spaced test
doseswere appliedwith the aim to exclude a dose dependency
(microcolonies can be recognized as toxic artifacts by a
missing dose dependency). Single experiments showed in
fact a tendency towards a dose trend. Such indications of
dose trends could however not be confirmed by use of more
closely spaced test doses. Therefore, in some experiments we
applied an unusual number of different test concentrations
(see Figure 3). If no toxicity occurred the compounds were
tested up to 5000 𝜇g/plate.
4. Discussion
We observed no mutagenic effects of the short chained
unsaturated hydrocarbons 1-pentene, 2-pentene, its stereo
isomers cis-, trans-2-pentene, and 3-methyl-1-butene, even so
we considered possible stereoselective effects in case of cis-
and trans-2-pentene, possible evaporation of the compounds
[8, 9], and bacterial repair [11]. YG7108 is sensitive for low
molecular weight compounds which are false negative by use
of the standard protocol and the parent strain TA1535. This
was shown for compounds up to 4 C-atoms such as allyl
chloride [10]. However, 1,2-epoxypentane exerted similar





































Figure 2: Bacterial mutagenicity of 1,2-epoxypentane in TA1535 and YG7108 without addition of S9-mix.With the aim to reduce the elevated
base rate (standard conditions (b)), the control plates (0𝜇g 1,2-epoxypentane) were placed in a separate incubator (a).


















3-Methyl-1-butene, TA98, TA100, and YG7108 +S9, gas-tight
Figure 3: Results for 3-methyl-1-butene in TA98, TA100, and
YG7108 with gas-tight preincubation and S9-mix. Three indepen-
dent experiments were performed with differently spaced dose
ranges.
bacterial mutagenicity in YG7108 and TA1535. Possibly C-5
compounds mark the cutoff for the substrates of the deleted
bacterial methyltransferases. In addition these experiments
show that the oxiranewhich can be formed in themetabolism
of 2-pentene would exert mutagenic effects in the bacterial
reverse mutation test.
Data on mutagenic effects of 1,2-epoxypentane are only
available from the summary of a study report which is
cited by ECHA [4]. Mutagenicity in TA1535 was observed
without S-9 mix from about 5000 𝜇g/plate (factor 2.3–2.6)
onward and with metabolic activation from about 2500𝜇g–
5000 𝜇g/plate (factor 1.7–2.0) onward [4]. In our experiments
1,2-epoxypentane was mutagenic at and above 100 𝜇g per
plate with a maximal increase of about 6-fold at 5000 𝜇g
per plate. This discrepancy can be explained by evaporation
of 1,2-epoxypentane into the incubator. In our experiments
this led to exceptional high reverse mutations in the negative
control plates and quite week mutagenic effects in the dosed
samples. We attained a spontaneous reverse mutation rate
within the historical range by placement of the control plates
in a separate incubator (Figures 2(a) and 2(b)). Therefore,
evaporation can lead to an underestimation of mutagenic
effects of short chained oxiranes. This is in accordance with
findings concerning ethylene oxide [3] and propylene oxide
[3, 8, 16].
The question remains open why branched and un-
saturated amylenes cannot be activated to mutagenic inter-
mediates in vitro. Possibly the investigated amylenes are not
efficiently epoxidized in vitro or oxidative metabolites which
may occur are subjected to detoxification by the bacterial
metabolism [17].
5. Conclusions
First, the investigated amylenes are not mutagenic, whereas
the corresponding epoxide of 1-pentene (1,2-epoxipentane)
BioMed Research International 5
exerted clear bacterialmutagenicity. Epoxidation of the inves-
tigated amylenes using rat liver S9-mixmay not to be effective
or is counterbalanced by detoxifying reactions. Second, weak
bacterial mutagenicity of low molecular weight compounds
such as 1,2-epoxipentane, ethylene-, or proplyene oxide can
be caused by evaporation of compounds.
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